Cryopreserved IL-4-treated macrophages attenuate murine colitis in an integrin β7-dependent manner

scientific article published on 9 December 2015

Cryopreserved IL-4-treated macrophages attenuate murine colitis in an integrin β7-dependent manner is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1068965792
P356DOI10.2119/MOLMED.2015.00193
P2888exact matchhttps://scigraph.springernature.com/pub.10.2119/molmed.2015.00193
P932PMC publication ID4818268
P698PubMed publication ID26701314

P50authorGabriella LeungQ42099320
P2093author name stringDerek M McKay
Jordan Iannuzzi
Arthur Wang
Björn Petri
José Luis Reyes
P2860cites workPD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cellsQ24677367
Macrophage heterogeneity in tissues: phenotypic diversity and functionsQ26861223
Adoptive immunotherapy for cancer: harnessing the T cell responseQ28262548
The M1 and M2 paradigm of macrophage activation: time for reassessmentQ29615845
Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosisQ33429032
A method for generation of bone marrow-derived macrophages from cryopreserved mouse bone marrow cellsQ33778379
Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitisQ34202877
Dendritic-cell-based therapeutic cancer vaccinesQ34360094
Failed renoprotection by alternatively activated bone marrow macrophages is due to a proliferation-dependent phenotype switch in vivoQ34372109
Crosstalk between sentinel and helper macrophages permits neutrophil migration into infected uroepitheliumQ34643625
CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages.Q34718815
Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?Q34779125
Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage functionQ35884586
Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activationQ36231523
Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD miceQ36339559
Advances in stem cell therapy for spinal cord injuryQ36357908
IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophagesQ36501243
Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Ralpha, IL-13Ralpha1, and gammac regulates relative cytokine sensitivityQ36946566
Stem cell therapy in inflammatory bowel disease: which, when and how?Q38105943
Stem cells as potential targeted therapy for inflammatory bowel diseaseQ38191335
Foxp3-expressing CD103+ regulatory T cells accumulate in dendritic cell aggregates of the colonic mucosa in murine transfer colitisQ38623517
Integrin alpha E(CD103)beta 7 mediates adhesion to intestinal microvascular endothelial cell lines via an E-cadherin-independent interactionQ40826621
Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblastsQ40852538
Splenic B cells from Hymenolepis diminuta-infected mice ameliorate colitis independent of T cells and via cooperation with macrophages.Q41632235
Regulation of obesity-related insulin resistance with gut anti-inflammatory agentsQ42174194
Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's diseaseQ42663033
Liposomes for specific depletion of macrophages from organs and tissuesQ43194945
In vitro-derived alternatively activated macrophages reduce colonic inflammation in miceQ43203596
Arginase activity in alternatively activated macrophages protects PI3Kp110δ deficient mice from dextran sodium sulfate induced intestinal inflammationQ44086481
Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cellsQ44217456
Bone marrow-derived alternatively activated macrophages reduce colitis without promoting fibrosis: participation of IL-10.Q44583364
Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine.Q50437860
SHIP-deficient, alternatively activated macrophages protect mice during DSS-induced colitis.Q52612704
The therapeutic helminth?Q55051382
Cutting Edge: Immunological Consequences and Trafficking of Human Regulatory Macrophages Administered to Renal Transplant RecipientsQ56989328
Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsisQ58862703
Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal diseaseQ59391845
Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhigh CD4+ T cellsQ73082037
Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophagesQ84396444
Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2Q84563119
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectcryopreservationQ1144664
P304page(s)924-936
P577publication date2015-12-09
P1433published inMolecular MedicineQ6895961
P1476titleCryopreserved Interleukin-4-Treated Macrophages Attenuate Murine Colitis in an Integrin β7 - Dependent Manner
P478volume21

Reverse relations

cites work (P2860)
Q90313359Alternatively activated macrophages promote resolution of necrosis following acute liver injury
Q53422544Discovering Macrophage Functions Using In Vivo Optical Imaging Techniques.
Q39440518Helminth Regulation of Immunity: A Three-pronged Approach to Treat Colitis
Q90699508Neuroimmunophysiology of the gut: advances and emerging concepts focusing on the epithelium
Q37589645Suppression of colitis by adoptive transfer of helminth antigen-treated dendritic cells requires interleukin-4 receptor-α signaling

Search more.